CFO
Callan Family Office Portfolio holdings
AUM
$3.17B
1-Year Est. Return
21.62%
1 Year Est. Return
+21.62%
AUM
$3.17B
AUM Growth
+$1.84B
(+138%)
Holding
941
Top Buys
| 1 | +$85.7M | |
| 2 | +$83M | |
| 3 | +$51.4M | |
| 4 |
Apple
AAPL
|
+$50.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$37.9M |
Top Sells
| 1 | +$2.79M | |
| 2 | +$1.88M | |
| 3 | +$1.84M | |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
+$1.36M |
| 5 |
iShares S&P 500 Value ETF
IVE
|
+$1.35M |
Sector Composition
| 1 | Technology | 23.34% |
| 2 | Financials | 14.8% |
| 3 | Healthcare | 9.6% |
| 4 | Industrials | 7.93% |
| 5 | Communication Services | 7.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TE
926
T1 Energy Inc
TE
$585M
| $12.7K | ﹤0.01% |
+10,288
|
|
||
927
Pacific Biosciences
PACB
$607M
| $12.4K | ﹤0.01% |
+10,024
|
|
||
928
Sutro Biopharma
STRO
$89M
| $11.5K | ﹤0.01% |
+16,177
|
|
||
929
FiscalNote
NOTE
$62.8M
| $10.8K | ﹤0.01% |
+1,677
|
|
||
930
ALX Oncology
ALXO
$93.7M
| $8.21K | ﹤0.01% |
+19,778
|
|
||
931
Opendoor
OPEN
$5.91B
| $6.3K | ﹤0.01% |
+11,823
|
|
||
|
TGB
932
Taseko Mines
TGB
$1.29B
| – | – |
-54,528
|
|
||
933
Vanguard Small-Cap ETF
VB
$68.4B
| – | – |
-1,247
|
|
||
|
X
934
DELISTED
US Steel
X
| – | – |
-6,165
|
|
||
935
Cabaletta Bio
CABA
$226M
| – | – |
-41,599
|
|
||
936
Criteo
CRTO
$1.07B
| – | – |
-7,347
|
|
||
|
DFS
937
DELISTED
Discover Financial Services
DFS
| – | – |
-16,316
|
|
||
938
Fate Therapeutics
FATE
$190M
| – | – |
-82,024
|
|
||
939
Hudbay
HBM
$6.26B
| – | – |
-53,883
|
|
||
940
iShares Russell 2000 Growth ETF
IWO
$13.4B
| – | – |
-843
|
|
||
941
RAPT Therapeutics
RAPT
$488M
| – | – |
-11,166
|
|